Stanford Medicine

Company

Related News

Q1 2026 trends point to AI, new therapies and policy shifts in sleep medicine

Apr 11, 2026

Q1 2026 sleep medicine trends include broader use of AI, expanding obstructive sleep apnea and narcolepsy treatments, and policy changes affecting reimbursement and access.

Injectable Drug Reprograms Cells to Regenerate Cartilage and Prevent Arthritis

Feb 14, 2026

Researchers from Stanford Medicine developed an injection that reprograms cells to regrow cartilage by blocking the protein 15-PGDH, offering potential treatment for osteoarthritis from aging or injury.